These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30900574)

  • 1. Consensus statement and guidelines for use of dilute atropine sulphate in myopia control.
    Kesarwani SS;
    Indian J Ophthalmol; 2019 Apr; 67(4):461-463. PubMed ID: 30900574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Concentration Atropine Eye Drops for Myopia Progression.
    Li FF; Yam JC
    Asia Pac J Ophthalmol (Phila); 2019; 8(5):360-365. PubMed ID: 31478936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
    Wei S; Li SM; An W; Du J; Liang X; Sun Y; Zhang D; Tian J; Wang N
    JAMA Ophthalmol; 2020 Nov; 138(11):1178-1184. PubMed ID: 33001210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of atropine 0.01% for the treatment of childhood myopia in European patients.
    Sacchi M; Serafino M; Villani E; Tagliabue E; Luccarelli S; Bonsignore F; Nucci P
    Acta Ophthalmol; 2019 Dec; 97(8):e1136-e1140. PubMed ID: 31197953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report.
    Yam JC; Li FF; Zhang X; Tang SM; Yip BHK; Kam KW; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2020 Jul; 127(7):910-919. PubMed ID: 32019700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Progressive Myopia in the Pediatric Population.
    Wagner RS
    J Pediatr Ophthalmol Strabismus; 2019 Mar; 56(2):72. PubMed ID: 30889259
    [No Abstract]   [Full Text] [Related]  

  • 7. Five-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 4 Report.
    Zhang XJ; Zhang Y; Yip BHK; Kam KW; Tang F; Ling X; Ng MPH; Young AL; Wu PC; Tham CC; Chen LJ; Pang CP; Yam JC
    Ophthalmology; 2024 Sep; 131(9):1011-1020. PubMed ID: 38494130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age Effect on Treatment Responses to 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study.
    Li FF; Zhang Y; Zhang X; Yip BHK; Tang SM; Kam KW; Young AL; Chen LJ; Tham CC; Pang CP; Yam JC
    Ophthalmology; 2021 Aug; 128(8):1180-1187. PubMed ID: 33422558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of progressive myopia with 0.01% Atropine in children and adolescents: an Italian 4-year follow-up study.
    Di Meglio M; Giunta P; Rechichi M; Trofa A; Galantuomo G; Galantuomo N; Palmieri S; Pacente L; Salducci M
    Clin Ter; 2024; 175(5):265-270. PubMed ID: 39400089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)-study protocol.
    Azuara-Blanco A; Logan N; Strang N; Saunders K; Allen PM; Weir R; Doherty P; Adams C; Gardner E; Hogg R; McFarland M; Preston J; Verghis R; Loughman JJ; Flitcroft I; Mackey DA; Lee SS; Hammond C; Congdon N; Clarke M
    Br J Ophthalmol; 2020 Jul; 104(7):950-955. PubMed ID: 31653669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choroidal Changes During and After Discontinuing Long-Term 0.01% Atropine Treatment for Myopia Control.
    Lee SS; Lingham G; Clark A; Read SA; Alonso-Caneiro D; Mackey DA
    Invest Ophthalmol Vis Sci; 2024 Aug; 65(10):21. PubMed ID: 39136629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which low-dose atropine for myopia control?
    Khanal S; Phillips JR
    Clin Exp Optom; 2020 Mar; 103(2):230-232. PubMed ID: 31489714
    [No Abstract]   [Full Text] [Related]  

  • 13. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results.
    Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kakehashi A
    Jpn J Ophthalmol; 2018 Sep; 62(5):544-553. PubMed ID: 29974278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout: Phase 3 Report.
    Yam JC; Zhang XJ; Zhang Y; Wang YM; Tang SM; Li FF; Kam KW; Ko ST; Yip BHK; Young AL; Tham CC; Chen LJ; Pang CP
    Ophthalmology; 2022 Mar; 129(3):308-321. PubMed ID: 34627809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial.
    Cui C; Li X; Lyu Y; Wei L; Zhao B; Yu S; Rong J; Bai Y; Fu A
    Sci Rep; 2021 Nov; 11(1):22267. PubMed ID: 34782708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 1% atropine eye drops in retarding progressive axial myopia in Indian eyes.
    Kothari M; Rathod V
    Indian J Ophthalmol; 2017 Nov; 65(11):1178-1181. PubMed ID: 29133646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of High Myopia in Children.
    Brown DD; Guo S; Wang FM; Wagner RS
    J Pediatr Ophthalmol Strabismus; 2018 Jul; 55(4):212-214. PubMed ID: 30024015
    [No Abstract]   [Full Text] [Related]  

  • 18. Reducing the progression of myopia with atropine: a long term cohort study of Olmsted County students.
    Kennedy RH; Dyer JA; Kennedy MA; Parulkar S; Kurland LT; Herman DC; McIntire D; Jacobs D; Luepker RV
    Binocul Vis Strabismus Q; 2000; 15(3 Suppl):281-304. PubMed ID: 11486796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness study of atropine for progressive myopia in Europeans.
    Polling JR; Kok RG; Tideman JW; Meskat B; Klaver CC
    Eye (Lond); 2016 Jul; 30(7):998-1004. PubMed ID: 27101751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for progressive myopia in the atropine therapy for myopia study.
    Loh KL; Lu Q; Tan D; Chia A
    Am J Ophthalmol; 2015 May; 159(5):945-9. PubMed ID: 25640408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.